{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:27:24Z","timestamp":1781522844752,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.semarthrit.2018.10.016","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T01:37:07Z","timestamp":1539999427000},"page":"1041-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antiphospholipid antibodies and renal transplant: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"48","author":[{"given":"Paul RJ","family":"Ames","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Merashli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3115","authenticated-orcid":false,"given":"Fabrizio","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-4125","authenticated-orcid":false,"given":"Jose","family":"Delgado-Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2018.10.016_bib0001","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40620-016-0317-2","article-title":"Renal involvement in primary antiphospholipid syndrome","volume":"29","author":"Marcantoni","year":"2016","journal-title":"J Nephrol"},{"issue":"3 Pt 1","key":"10.1016\/j.semarthrit.2018.10.016_bib0003","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lpm.2011.11.012","article-title":"Kidney allograft: a target for systemic disease","volume":"41","author":"Canaud","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0004","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0005","unstructured":"Wells G.A., Shea B., O'Connell D., Peterson J., Welch V., Losos M. et al. Ottawa hospital research institute. the newcastle-ottawa scale (NOS) for assessing the quality of non randomized studies in meta-analysis. Available from URL: www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/sim.2528","article-title":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events","volume":"26","author":"Bradburn","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0007","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0895-4356(99)00204-8","article-title":"Misleading funnel plot for detection of bias in meta-analysis","volume":"253","author":"Tang","year":"2000","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0008","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0009","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.transproceed.2009.06.104","article-title":"Prospective study on autoantibodies against apolipoprotein H (beta2GPI) in several clinical parameters from patients with terminal renal failure and functioning renal transplants","volume":"41","author":"Ram\u00edrez","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0041-1345(97)00419-3","article-title":"Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients","volume":"29","author":"Ducloux","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0011","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0041-1345(98)01514-0","article-title":"Antiphospholipid antibody syndrome and posttransplant renal thrombosis","volume":"31","author":"Vaidya","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0041-1345(98)01513-9","article-title":"Anticardiolipin antibodies after kidney transplantation in patients without connective tissue disease","volume":"31","author":"Grandtnerov\u00e1","year":"1999","journal-title":"Transplant Proc"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2018.10.016_bib0013","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1432-2277.2000.tb02122.x","article-title":"Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies","volume":"13","author":"Wagenknecht","year":"2000","journal-title":"Transplant Int"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0014","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/00007890-200004150-00023","article-title":"Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study","volume":"69","author":"Vaidya","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/00007890-200109270-00016","article-title":"Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis","volume":"72","author":"Friedman","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0016","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1191\/0961203303lu401oa","article-title":"Antiphospholipid antibodies and renal transplantation: a risk assessment","volume":"12","author":"McIntyre","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0017","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1755.2003.00155.x","article-title":"Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients","volume":"64","author":"Ducloux","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0018","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0272-6386(03)00860-6","article-title":"Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation","volume":"42","author":"Nampoory","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0019","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1046\/j.1600-6143.2004.00602.x","article-title":"Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation","volume":"4","author":"Forman","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0020","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/ndt\/gfk017","article-title":"Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants","volume":"21","author":"Nybo","year":"2006","journal-title":"Nephrol Dialys Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-2006-944306","article-title":"Antiphospholipid antibody syndrome: a priori a contraindication to kidney transplantation?","volume":"38","author":"Rubenwolf","year":"2007","journal-title":"Aktuelle Urol"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0022","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1399-0012.2008.00825.x","article-title":"Antiphospholipid antibodies after renal transplantation and cardiovascular disease","volume":"22","author":"Fernandez-Fresnedo","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0023","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1600-6143.2010.03233.x","article-title":"Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies","volume":"10","author":"Canaud","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0024","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/ndt\/gfq791","article-title":"Thrombophilic factors in Stage V chronic kidney disease patients are largely corrected by renal transplantation","volume":"26","author":"Ghisdal","year":"2011","journal-title":"Nephrol Dialys Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1399-0012.2012.01625.x","article-title":"Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome","volume":"26","author":"Vaidya","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0026","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.transproceed.2013.02.043","article-title":"Antiphospholipid antibodies in renal allograft recipients","volume":"45","author":"Furma\u0144czyk-Zawiska","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/641962","article-title":"Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein I antibodies in patients with end stage renal disease","volume":"2014","author":"Serrano","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0028","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1681\/ASN.2014030228","article-title":"Association of early kidney allograft failure with preformed IgA antibodies to \u03b22-glycoprotein I","volume":"26","author":"Morales","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0029","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/TP.0000000000001199","article-title":"The presence of pretransplant antiphospholipid antibodies IgA anti-beta-2-glycoprotein I as a predictor of graft thrombosis after renal transplantation","volume":"101","author":"Morales","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3389\/fimmu.2018.00468","article-title":"Pretransplant IgA-anti-beta 2 glycoprotein I antibodies as a predictor of early graft thrombosis after renal transplantation in the clinical practice: a multicenter and prospective study","volume":"9","author":"Morales","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0031","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfx353","article-title":"Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey","author":"Gauthier","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0032","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9343(96)00060-5","article-title":"Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry","volume":"100","author":"Finazzi","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0033","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"\u03b22-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0034","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MNH.0000000000000190","article-title":"Ischemia as a factor affecting innate immune responses in kidney transplantation","volume":"25","author":"Kasimsetty","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5500\/wjt.v5.i2.52","article-title":"Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment","volume":"5","author":"Salvadori","year":"2015","journal-title":"World J Transplant"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0036","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ckj\/sfx091","article-title":"Chronic kidney disease, kidney transplantation and oxidative stress: a new look to successful kidney transplantation","volume":"11","author":"Tabriziani","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0037","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1191\/096120300677692516","article-title":"Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study","volume":"9","author":"Ames","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0038","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0961203315603146","article-title":"Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4","volume":"25","author":"Laplante","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0039","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mcna.2016.01.002","article-title":"Acute and chronic allograft dysfunction in kidney transplant recipients","volume":"100","author":"Goldberg","year":"2016","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0040","first-page":"5272","article-title":"Expression of immunoglobulin A in human mesangial cells and its effects on cell apoptosis and adhesion","volume":"17","author":"Deng","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9036450","article-title":"Chronic kidney disease and disproportionally increased cardiovascular damage: does oxidative stress explain the burden?","volume":"2017","author":"Duni","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0042","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3389\/fimmu.2017.00630","article-title":"The antibody-secreting cell response to infection: kinetics and clinical applications","volume":"8","author":"Carter","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0043","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood-2003-01-0180","article-title":"Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals","volume":"102","author":"Lieby","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0044","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0711515105","article-title":"Podocytes use FcRn to clear IgG from the glomerular basement membrane","volume":"105","author":"Akilesh","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0045","doi-asserted-by":"crossref","first-page":"F358","DOI":"10.1152\/ajprenal.0164.2001","article-title":"FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells","volume":"282","author":"Kobayashi","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0046","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.V114632","article-title":"Characterization and localization of the neonatal Fc receptor in adult human kidney","volume":"11","author":"Haymann","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2018.10.016_bib0047","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1681\/ASN.2008090976","article-title":"Renal FcRn reclaims albumin but facilitates elimination of IgG","volume":"20","author":"Sarav","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218305912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218305912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:58:10Z","timestamp":1758733090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017218305912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0049017218305912"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.016","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibodies and renal transplant: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}